Peptides, artificial antigens, polyclonal antibodies and applications for preparing universal detection antibodies for polytype adenovirus
By preparing polypeptides P1-A, P1-C and P2, combining keyhole hemocyanin, polyclonal antibodies are obtained, which solves the problem of difficulty in detecting multiple types of adenoviruses in the prior art, and realizes the use of multiple types of adenoviruses The stable and rapid detection of viruses, especially in the detection of adenovirus in group A-F, significantly improved the effect.
Patent Information
- Application Number
- CN202410916903.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-10
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-10
AI Technical Summary
There is a lack of available antibodies with universal detection characteristics in the prior art, requiring complex viral culture quantification processes or at risk of infection, making it difficult to effectively detect various types of adenoviruses, especially group A, group D and group F adenoviruses.
By preparing polypeptides P1-A, P1-C and P2, combining keyhole hemocyanin as carrier protein, polyclonal antibodies are obtained, which are used to detect various types of adenoviruses, avoiding the virus culture process and infection risks.
Stable and rapid detection of various types of adenoviruses is achieved, with the effect being better than or equivalent to antibodies obtained from whole virus immunity, especially when detecting A-F group adenoviruses, the detection ability is significantly improved.
Smart Images

Figure CN118459559B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of antibody preparation, and in particular relates to polypeptides, artificial antigens, polyclonal antibodies and applications thereof for preparing universal detection antibodies for polytype adenoviruses. Background Art
[0002] Human adenovirus (HAdV) is a non-enveloped, icosahedral, linear double-stranded DNA virus. According to its nucleotide homology, coagulation properties, biochemical and bioinformatics analysis characteristics, it is divided into different types, with a total of AG 7 subgenera. It is a group of viruses that can cause diseases in the respiratory tract, eyes, digestive tract, urethra and bladder, especially in children and the elderly. Because it can infect different tissues and has different tissue tropism, it has also been developed into a variety of vector systems. Whether it is the study of its pathogenic mechanism or the study of vector characteristics, a powerful verification tool is needed. Universal adenovirus detection antibodies can be used in various immunological tests. The antibodies with universal detection characteristics currently obtained are mostly from whole virus immunization, which requires complex virus culture quantitative process or infection risk. There is currently a lack of immunogenic peptides that can obtain antibodies with universal detection characteristics. Summary of the invention
[0003] The purpose of the present invention is to provide a polypeptide, an artificial antigen, a polyclonal antibody and its application for preparing a universal detection antibody for multiple types of adenoviruses. The antibody prepared by the polypeptide of the present invention can detect multiple types of adenoviruses without the need for a complex virus culture quantitative process and without the risk of infection.
[0004] The present invention provides a group of polypeptides for preparing universal detection antibodies for polymorphic adenoviruses, wherein the polypeptides include P1-A, P1-C and P2, the amino acid sequence of P1-A is shown in SEQ ID NO.1, the amino acid sequence of P1-C is shown in SEQ ID NO.2, and the amino acid sequence of P2 is shown in SEQ ID NO.3.
[0005] The present invention also provides an artificial antigen obtained by coupling the polypeptide described in the above technical solution with a carrier protein.
[0006] Preferably, the carrier protein comprises keyhole limpet hemocyanin.
[0007] The present invention also provides a universal detection antibody for polymorphic adenovirus, which is obtained by immunizing an animal with the artificial antigen described in the above technical solution.
[0008] Preferably, the types of adenovirus detected by the antibody include one or more of type A adenovirus, type B adenovirus, type C adenovirus, type D adenovirus, type E adenovirus and type F adenovirus.
[0009] The present invention also provides a method for preparing the antibody described in the above technical solution, comprising the following steps:
[0010] Animals are immunized with artificial antigens, and the animal serum is purified to obtain purified antibodies.
[0011] Preferably, after purification, the antibody titer is >1:32000.
[0012] The present invention also provides the use of the polypeptide described in the above technical solution, the artificial antigen described in the above technical solution, the antibody described in the above technical solution, or the antibody prepared by the preparation method described in the above technical solution in the preparation of a reagent for detecting adenovirus penton protein.
[0013] The present invention also provides the use of the polypeptide described in the above technical solution, the artificial antigen described in the above technical solution, the antibody described in the above technical solution, or the antibody prepared by the preparation method described in the above technical solution in the preparation of a reagent for detecting polymorphic adenovirus.
[0014] The present invention also provides the use of the polypeptide described in the above technical solution, the artificial antigen described in the above technical solution, the antibody described in the above technical solution, or the antibody prepared by the preparation method described in the above technical solution in preparing a diagnostic kit for adenovirus-induced diseases.
[0015] The present invention provides a polypeptide for preparing a universal detection antibody for polymorphic adenoviruses. The immunogen for antibody preparation of the present invention (i.e., the polypeptide of the present invention) is derived from only a partial peptide segment of a viral coat protein, but can achieve a virus detection effect similar to or better than that of whole virus immunization. No complicated virus culture quantitative process or infection risk is required, and the immunogen (synthetic polypeptide) can be obtained stably and quickly. Especially for adenoviruses of groups A, D, and F that infect the intestine, it is difficult to detect them by plaque assay or TCID 50 To quantify (it is difficult for cells to show obvious pathological changes when this type of adenovirus is infected at low titers), which greatly hinders the subsequent research on these adenoviruses. The antibody of the present invention has been verified to have a better or equivalent detection effect on this type of adenovirus than Ad5 antibody (type 5 adenovirus whole virus immune antibody). The technical solution of polypeptide combined immunization is irreplaceable. Although there are other adenovirus whole virus immunizations that can detect multiple types of adenoviruses, the types detected are mostly limited to types with similar phylogenetic development to this type of adenovirus. For example, the antibody (Ad5 antibody) obtained by type 5 whole virus immunization shown in the embodiment of the present invention has the best detection effect on type 2 and type 6 belonging to group C, but the detection effect of group A, group D and group F, which are relatively far in phylogeny, is poor, and even cannot be detected when the concentration of the primary antibody and the secondary antibody are the same. The antibody obtained by polypeptide combined immunization of the present invention can detect multiple representative types of adenoviruses of group AF well through various methods, and the effect is stable. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0017] Figure 1 The result graph of the Western-blot method P antibody detection of 11 types of adenovirus provided by the present invention; wherein, M is a molecular weight standard, 2 is adenovirus type 2 (group C), 6 is adenovirus type 6 (group C), 4 is adenovirus type 4 (group E), 3 is adenovirus type 3 (group B), 7 is adenovirus type 7 (group B), 14 is adenovirus type 14 (group B), 55 is adenovirus type 55 (group B), 8 is adenovirus type 8 (group D), 31 is adenovirus type 31 (group A), 40 is adenovirus type 40 (group F), 41 is adenovirus type 41 (group F), and 293 is 293 cells (negative control);
[0018] Figure 2 The results of the P antibody provided by the present invention detecting intracellular adenovirus by cellular immunology methods (fluorescence and enzyme); wherein the left figure is an enzyme colorimetric result after adenovirus infects cells (the upper left figure is observed under a 20x objective lens, and the lower left figure is observed under a 40x objective lens), the upper right figure is a fluorescence colorimetric result after adenovirus infects cells (observed under a 20x objective lens), and the lower right figure is an immunofluorescence result after bright field light is added to the upper right figure;
[0019] Figure 3 The results of detecting the representative strain of group A adenovirus (group A type 31 adenovirus, A31) infected five cell lines by the P antibody provided by the present invention by the cell immunoenzymatic method for 48 hours (observed under a 20x objective); the infected cell lines are 293 (human embryonic kidney cells), A549 (human non-small cell lung cancer cells), Caco-2 (human colon adenocarcinoma cells), Hela (cervical cancer cells) and Hep-2 (human laryngeal epidermoid carcinoma cells);
[0020] Figure 4 The results of detecting five cell lines infected with representative strains of group B adenovirus (group B type 3 adenovirus, B3) by the P antibody provided by the present invention by cellular immunoenzymatic method for 48 hours (observed under a 20x objective); the infected cell lines are 293 (human embryonic kidney cells), A549 (human non-small cell lung cancer cells), Caco-2 (human colon adenocarcinoma cells), Hela (cervical cancer cells) and Hep-2 (human laryngeal epidermoid carcinoma cells);
[0021] Figure 5The results of detecting five cell lines infected with representative strains of group C adenovirus (group C type 2 adenovirus, C2) by the P antibody provided by the present invention by cellular immunoenzymatic method for 48 hours (observed under a 20x objective); the infected cell lines are 293 (human embryonic kidney cells), A549 (human non-small cell lung cancer cells), Caco-2 (human colon adenocarcinoma cells), Hela (cervical cancer cells) and Hep-2 (human laryngeal epidermoid carcinoma cells);
[0022] Figure 6 The results of detecting five cell lines infected with representative strains of group D adenovirus (group D type 8 adenovirus, D8) by the P antibody provided by the present invention by cellular immunoenzymatic method for 48 hours (observed under a 20x objective); the infected cell lines are 293 (human embryonic kidney cells), A549 (human non-small cell lung cancer cells), Caco-2 (human colon adenocarcinoma cells), Hela (cervical cancer cells) and Hep-2 (human laryngeal epidermoid carcinoma cells);
[0023] Figure 7 The results of detecting five cell lines infected with representative strains of group E adenovirus (group E type 4 adenovirus, E4) by the P antibody provided by the present invention by cellular immunoenzymatic method for 48 hours (observed under a 20x objective); the infected cell lines are 293 (human embryonic kidney cells), A549 (human non-small cell lung cancer cells), Caco-2 (human colon adenocarcinoma cells), Hela (cervical cancer cells) and Hep-2 (human laryngeal epidermoid carcinoma cells);
[0024] Figure 8 The result of detecting five cell lines infected with representative strains of group F adenovirus (group F adenovirus type 41, F41) by the P antibody provided by the present invention by cellular immunoenzymatic method for 48 hours (observed under a 20x objective); the infected cell lines are 293 (human embryonic kidney cells), A549 (human non-small cell lung cancer cells), Caco-2 (human colon adenocarcinoma cells), Hela (cervical cancer cells) and Hep-2 (human laryngeal epidermoid carcinoma cells);
[0025] Fig. 9 This is a result diagram of the detection of adenovirus strains by the ELISA method using the P antibody provided by the present invention; wherein, the viruses coated in the first to third columns of the left figure are A31 (A group 31 adenovirus), F41 (F group 41 adenovirus) and C6 (C group 6 adenovirus), respectively, and the right figure is the absorbance result measured by an ELISA reader at 450nm;
[0026] Fig.10This is a comparison result diagram of the effects of the P antibody, 31penton antibody and Ad5 antibody provided by the present invention on detecting polytype adenovirus (Western-blot method); wherein the upper diagram is a diagram of the detection result of the Ad5 antibody; the middle diagram is a diagram of the detection result of the adenovirus 31-type penton immune antibody; and the lower diagram is a diagram of the detection result of the P antibody;
[0027] Fig.11 This is a comparison result of the effects of the P antibody and Ad5 antibody provided by the present invention on detecting polytype adenovirus (cellular immunoenzymatic method, observed under a 20x objective lens);
[0028] Fig.12 The present invention provides a comparative result diagram of the effects of the P antibody and the Ad5 antibody on detecting polytypic adenoviruses (ELISA method); wherein, in the left figure, the viruses coated in rows 1 to 8 are A31 (adenovirus type 31 of group A), B3 (adenovirus type 3 of group B), C2 (adenovirus type 2 of group C), D8 (adenovirus type 8 of group D), E4 (adenovirus type 4 of group E), F40 (adenovirus type 40 of group F), F41 (adenovirus type 41 of group F) and 2% MEM (negative control), the 5th and 6th columns are detected using the P antibody, and the 7th and 8th columns are detected using the Ad5 antibody; the right figure shows the absorbance results measured by an ELISA reader at 450 nm. DETAILED DESCRIPTION
[0029] The present invention provides a group of polypeptides for preparing a universal detection antibody for polymorphic adenovirus, wherein the polypeptides include P1-A, P1-C and P2, wherein the amino acid sequence of P1-A is shown in SEQ ID NO.1, the amino acid sequence of P1-C is shown in SEQ ID NO.2, and the amino acid sequence of P2 is shown in SEQ ID NO.3:
[0030] P1-A: LPDMMQDPVTFRSSRQVSNYPVVAAELMPVHA, SEQ ID NO.1;
[0031] P1-C: LPDMMQDPVTFRSTSQISNFPVVGAELLPVHS, SEQ ID NO.2;
[0032] P2:TTVSENVPALTDHGTLPL, SEQ ID NO.3.
[0033] The present invention uses antigen analysis software and phage peptide library to screen and obtain three antigenic polypeptides of adenovirus penton protein. The polypeptide of the present invention is preferably commissioned to be synthesized by Jier Biochemical (Shanghai) Co., Ltd., and HPLC and MS identification are correct. Based on the polypeptide, the present invention preferably obtains polyclonal antibodies for the detection of polytype adenovirus by combined immunization of rabbits.
[0034] The present invention also provides an artificial antigen obtained by coupling the polypeptide described in the above technical solution with a carrier protein. In the present invention, the carrier protein preferably includes keyhole limpet hemocyanin (KLH). The present invention has no special limitation on the source of the carrier protein, and a conventional commercial product can be used. For example, the commercial information of KLH is preferably Merck Millipore, item number 374805-1GM.
[0035] The present invention also provides a universal detection antibody for polytype adenovirus (P antibody for short), which is obtained by immunizing an animal with the artificial antigen described in the above technical solution. In the present invention, the types of adenovirus detected by the antibody preferably include one or more of type A adenovirus, type B adenovirus, type C adenovirus, type D adenovirus, type E adenovirus and type F adenovirus.
[0036] The present invention also provides a method for preparing the antibody described in the above technical solution, comprising the following steps:
[0037] Animals are immunized with artificial antigens, and the animal serum is purified to obtain purified antibodies.
[0038] The present invention has no special limitation on the preparation method of the artificial antigen, and the artificial antigen can be obtained by coupling the polypeptide of the present invention with a coupling protein. In the present invention, the polypeptide is preferably commissioned to be synthesized by a company, and the purity of the synthesized polypeptide is preferably >95%. In the present invention, animals are immunized with artificial antigens, and the animal serum is purified to obtain purified antibodies. In the present invention, the animal is preferably a white rabbit, and more preferably a New Zealand white rabbit. The purification method of the present invention is preferably affinity purification. After purification, the present invention preferably uses the Elisa method to detect the titer of the purified antibody. In the present invention, after purification, the titer of the antibody is preferably >1:32000.
[0039] The present invention also provides the use of the polypeptide described in the above technical solution, the artificial antigen described in the above technical solution, the antibody described in the above technical solution, or the antibody prepared by the preparation method described in the above technical solution in preparing a reagent for detecting adenovirus penton protein.
[0040] The present invention also provides the use of the polypeptide described in the above technical solution, the artificial antigen described in the above technical solution, the antibody described in the above technical solution, or the antibody prepared by the preparation method described in the above technical solution in the preparation of a reagent for detecting polymorphic adenovirus.
[0041] The present invention also provides the use of the polypeptide described in the above technical solution, the artificial antigen described in the above technical solution, the antibody described in the above technical solution, or the antibody prepared by the preparation method described in the above technical solution in preparing a diagnostic kit for adenovirus-induced diseases.
[0042] To further illustrate the present invention, the polypeptides, artificial antigens, polyclonal antibodies and applications for preparing universal detection antibodies for polytype adenovirus provided by the present invention are described in detail below in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.
[0043] Method 1: Polyclonal antibody preparation method
[0044] 1. Antigen preparation (2-3 weeks)
[0045] Peptide synthesis and KLH conjugation.
[0046] The peptides were synthesized by 9-fluoromethoxycarbonyl (Fmoc) solid phase synthesis method, and purified by high performance liquid chromatography (HPLC) with a purity of 95%. The purified peptides (three peptides) were condensed with keyhole limpet hemocyanin (KLH) by the EDCI method to obtain a peptide-hemocyanin compound (immunogen).
[0047] 2. Immunization (8-10 weeks)
[0048] Prepare 2 New Zealand rabbits, take 200 μg of HLK-coupled peptide (dissolved in 0.1 mol / L PBS, pH 7.4, 1 mL) and mix thoroughly with an equal volume of Freund's adjuvant for emulsification and set aside. Each rabbit is subcutaneously injected at 4 different sites, two at the back and two at the thighs, each with 250 μL.
[0049] Perform the immunization operation according to the process shown in Table 1:
[0050] Table 1 Immunization process
[0051]
[0052] 3. Purify antibodies and perform ELISA testing (2-3 weeks)
[0053] Antigen affinity purification:
[0054] Step 1: Antigen affinity purification;
[0055] 1) Preparation of antigen affinity column: The peptide was coupled to the cross-linked agarose matrix pre-activated with cyanogen bromide.
[0056] First, wash the ethanol in the matrix with 10 volumes of pure water and drain the matrix; use coupling buffer (0.2 mol / LNa2CO3 and 0.5 mol / L NaCl, pH 10) to dissolve the peptide into 7 mg / mL peptide solution; mix the activated matrix and peptide solution at a ratio of 1:1 and react at 25°C for about 20 h; use Nanodrop to measure the concentration of the effluent and calculate the coupling efficiency. A value greater than 95% indicates that the peptide coupling is successful; after the coupling, wash the peptide solution with 10 column volumes of deionized water; add 1 mol / L ethanolamine for 8 h to block the unreacted active groups; after the reaction, rinse with deionized water.
[0057] 2) Purification of antigen-specific antibodies The above antigen affinity matrix was loaded onto a gravity column. Before loading, the affinity column was rinsed with 5 column volumes of 0.1 mol / L, pH 9.5 Na2HPO4·12H2O to balance the column. Immune rabbit serum was added, 10 mL each time, and the effluent was discarded. Five column volumes of 0.1 mol / L, pH 9.5 Na2HPO4·12H2O were added for rinsing, and the rinsing solution was discarded. The antibody was eluted with 3 column volumes of 0.2 mol / L, pH 4.0 citric acid solution. After collecting the eluate, 1 mol / L, pH 8.0 Tris buffer was immediately added for neutralization. The eluted antibody solution was dialyzed with PBS solution for 2 h. After filtering with a 0.22 μm filter, it was stored at 4°C for later use.
[0058] Step 2: ELISA test.
[0059] 0.6 μg / well polypeptide was coated on a 96-well ELISA plate using pH 9.6 carbonate buffer and incubated at 4°C overnight; 200 μL of blocking solution (2% BSA, prepared in PBS) was added to each well and incubated at 37°C for 2 h; the purified antibody was diluted in multiples; 100 μL of the diluted antibody was added to each well and incubated at 37°C for 1 h; 100 μL of HRP-labeled goat anti-rabbit IgG (H+L) (dilution 1:5 000, prepared in blocking solution) was added to each well and incubated at 37°C for 30 min; after 10 min of color development with TMB color development solution, the color development reaction was terminated with 2 mol / L dilute sulfuric acid, and the OD was measured with an ELISA reader. 450 nm value. OD of the detection well 450 nm value average / negative control well OD 450 If the average value of nm>2.1, it is judged as positive; the lowest dilution factor of the antibody that can detect a positive signal is the antibody titer.
[0060] 4. Verification
[0061] The antibody titer was proved to be >1:32K by ELISA method.
[0062] Table 2 Elisa results of antigen affinity purified polyclonal antibodies
[0063]
[0064] (-): Negative serum, OD < 0.2 at 1:1000 dilution
[0065] SA: Antigen affinity purified antibody, OD>1.0 at 1:64000 dilution
[0066] Method 2: Adenovirus west-blot detection
[0067] 1. Obtaining various types of adenovirus: After adenovirus infects 293 cells, harvest them when 80% of the cells show pathological changes, freeze and thaw them three times at -80°C to break the cells, centrifuge at 1500g for 30 minutes, and aspirate the supernatant, which is the adenovirus supernatant. At the same time, harvest 293 cells that are not infected with adenovirus, and treat the supernatant obtained by the above method as a negative control.
[0068] 2. Sample preparation: Take 80 μL of adenovirus supernatant and add 20 uL of 5× loading buffer, heat in boiling water for 5 minutes, and centrifuge briefly for later use.
[0069] 3. Prepare electrophoresis gel according to conventional methods and perform SDS-PAGE, with 15 μL of prepared sample loaded per lane.
[0070] 4. Protein transfer:
[0071] 1) After electrophoresis, cut the gel strip into appropriate size and place it in transfer buffer for equilibrium.
[0072] 2) Membrane treatment: Pre-cut filter paper and PVDF membrane (Millipore Corp) to the same size as the gel strip and immerse them in transfer buffer for equilibrium.
[0073] 3) Transfer: Use a transfer device (Bio-Rad Laboratories, Inc) to transfer the separated proteins to the PVDF membrane according to conventional methods.
[0074] 4. Immune response:
[0075] 1) Wash the membrane with PBST for 5 min × 3 times.
[0076] 2) Add blocking solution (5% skim milk), shake steadily, and incubate at 4°C overnight.
[0077] 3) Discard the blocking solution and rinse once with a small amount of PBST.
[0078] 4) Add primary antibody [P antibody (homemade, rabbit source) and / or commercially available adenovirus antibody (Abcam, ab36851, goat source), 31penton antibody (homemade, rabbit source)], dilute the antibody to 10 mL with blocking solution (5% skim milk) at 1 μg / mL, and incubate at 37°C for 2 h.
[0079] 5) Discard the primary antibody and wash the membrane with PBST for 10 min × 3 times.
[0080] 6) Add horseradish peroxidase-conjugated secondary antibodies [goat anti-rabbit (Jackson, 111-035-003) and donkey anti-goat (Abcam, ab6885)], dilute the antibody to 10 mL with blocking solution (1% skim milk) at 1 μg / mL, and incubate at room temperature for 1 hour.
[0081] 7) Discard the secondary antibody and wash the membrane with PBST for 10 min × 3 times.
[0082] 8) Add DAB color developing solution, protect from light until a band appears, then put it into double distilled water to terminate the reaction.
[0083] Method 3: Adenovirus Cell Immunology Detection (Immunoenzymology and Immunofluorescence)
[0084] 1) 293 cells were propagated into 12-well plates until each well was 40% confluent. Culture medium (MEM+10% FBS+1% PS) was added to each well to make up to 1 mL. The cells were cultured at 37°C, 5% CO2 for 1 day. Adenovirus infection was performed after the cells reached 60-70% confluence.
[0085] 2) Dilute adenovirus to the required concentration with MEM, add 0.5 mL to each well of a 12-well plate, and incubate at 37°C, 5% CO2 for 2 h.
[0086] 3) Aspirate the adenovirus dilution solution, wash twice with 1 mL PBS, add 1 mL culture medium (MEM + 2% FBS + 1% PS) to each well, and incubate at 37°C, 5% CO2 for 2 days.
[0087] 4) Aspirate the culture medium and add 0.5 mL of methanol to each well and fix at -20°C for 20 min. Then discard the methanol and continue with the next experiment or store at -20°C until the next experiment.
[0088] 5) Wash three times with rinse buffer (PBS containing 1% bovine serum albumin), 5 minutes each time.
[0089] 6) Add primary antibody [P antibody (homemade, rabbit source) and / or commercially available adenovirus antibody (Abcam, ab36851, goat source), diluted to 1 μg / mL] diluted with rinse buffer, add 0.5 mL to each well, and incubate overnight.
[0090] 7) Wash with rinse solution 3 times, 5 minutes each time.
[0091] Immunoenzymology
[0092] 8) Add horseradish peroxidase-labeled secondary antibodies [goat anti-rabbit (Jackson, 111-035-003) and donkey anti-goat (Abcam, ab6885), diluted to 1 μg / mL] diluted in the rinse buffer, add 0.5 mL to each well, and incubate at room temperature for 2 h.
[0093] 9) Wash with rinse solution 3 times, 10 minutes each time.
[0094] 10) Add DAB colorimetric solution, 0.5 mL per well, color development in the dark, discard the colorimetric solution after 1-5 minutes (the brown color of the cells can be observed under a microscope), wash twice with rinse solution, 5 minutes each time. Finally, add 1 mL PBS to each well and observe the color development of the cells under a microscope.
[0095] Immunofluorescence
[0096] 8) Add FITC-labeled secondary antibodies [goat anti-rabbit (Jackson, 111-095-003) and donkey anti-goat (BBI, D110111-0100), diluted to 1 μg / mL] diluted in the rinse buffer, add 0.5 mL to each well, and incubate at room temperature for 2 h.
[0097] 9) Wash with rinse buffer 3 times, 10 min each time. Finally, add 1 mL of PBS to each well and observe cell fluorescence under a microscope.
[0098] Method 4: ELISA
[0099] 1) Dilute the virus solution to be tested with coating solution (0.1M carbonate buffer) to 4μg / mL (or dilute to a certain concentration as needed), add 100μL to each well of a plastic microplate, and place at 4℃ for 20-22 hours.
[0100] 2) The next day, remove the coated material, drain and dry it. Wash it three times with 0.02mol / L PBS-T, pH 7.4, with an interval of 3 minutes each time.
[0101] 3) Add 2% BSA (150 μL / well) for blocking, incubate at 4°C overnight or at 37°C for at least 1-2 hours. Discard the blocking solution and wash three times with 0.02 mol / L PBS-T, with an interval of 3 minutes each time (3 minutes × 3 times).
[0102] 4) Dilute the primary antibody as needed and add 100 μL to each well. Place in a 37°C water bath for 2 hours, remove from the water bath, air dry, and wash for 3 minutes x 3 times.
[0103] 5) Add enzyme-labeled antibody, dilute as needed, add 100 μL to each well, incubate in a 37°C water bath for 30 minutes, and then wash for 3 minutes x 3 times.
[0104] 6) Add 100 μL of the newly prepared substrate solution to each well and place in a 37°C water bath for 10 minutes. After taking out from the water bath, add 50 μL of 2 mol / L H2SO4 to each well to terminate the reaction and measure the OD value (wavelength 450 nm) using an enzyme-labeled spectrophotometer.
[0105] 7) Calculate the measurement results and use the control well to adjust the OD value to zero. Perform double-well measurement on each sample and take the average OD value.
[0106] A positive result was determined when (OD value of the sample to be tested / OD value of the negative control) > 2.1 or the OD value of the negative control plus 2 standard deviations.
[0107] Example 1
[0108] The P antibody can detect 11 types of adenovirus by Western-blot method (see Figure 1 ).
[0109] The adenovirus samples of various types are from adenovirus isolates in our laboratory and have been sequenced by three coat protein genes. The genebank sequence numbers are detailed in Table 3, and the detection methods are detailed in Method 2. P antibody can detect the coat penton protein (arrowed band) of 11 representative adenovirus strains of group AF by this method. The P antibody dilution concentration is 3μg / mL, and the horseradish-labeled goat anti-rabbit secondary antibody dilution concentration is 1μg / mL. 293 in the figure refers to 293 cells, which are obtained as negative controls according to step 1 in Method 2.
[0110] Table 3 Adenovirus coat protein genebank sequence numbers
[0111]
[0112] Example 2
[0113] P antibody can detect intracellular adenovirus by cell-mediated immunohistochemistry (fluorescence and enzyme) (see Figure 2 , taking adenovirus type 31 infection as an example).
[0114] The detection method is detailed in Method 3. P antibody can detect adenovirus that has infected 293 cells (human embryonic kidney cells) and replicated through this method. The left picture is the result of immunoenzyme colorimetry after adenovirus infected cells (the upper left picture is observed under a 20x objective lens, and the lower left picture is observed under a 40x objective lens). The upper right picture is the immunofluorescence colorimetry after adenovirus infected cells (observed under a 20x objective lens). The lower right picture is the upper right picture with bright field light added, and it can be seen that the fluorescence is located in the cell.
[0115] Example 3
[0116] P antibody can detect representative strains of adenovirus group AF that infect five common cell lines by cell-mediated immunoenzymatic methods (see Figure 3~Figure 8 The infected adenoviruses were A31 (adenovirus type 31 of group A), B3 (adenovirus type 3 of group B), C2 (adenovirus type 2 of group C), D8 (adenovirus type 8 of group D), E4 (adenovirus type 4 of group E), and F41 (adenovirus type 41 of group F). The infected cell lines were 293 (human embryonic kidney cells), A549 (human non-small cell lung cancer cells), Caco-2 (human colon adenocarcinoma cells), Hela (cervical cancer cells), and Hep-2 (human laryngeal epidermoid carcinoma cells).
[0117] The detection method is detailed in Method 3. The P antibody can detect different types of adenoviruses that replicated in large quantities after infecting five cell lines for 48 hours. All results are obtained by enzyme staining under a 20x objective. Different types of adenoviruses have different infection characteristics, and the color development results obtained after infecting different cell lines are different.
[0118] Example 4
[0119] P antibodies can be detected by ELISA method adenovirus strains (see Fig. 9 ).
[0120] The P antibody was tested for its ability to recognize three adenoviruses, A31, F41, and C6, using the ELISA method. The negative control was 2% MEM (the culture medium used for virus isolation: MEM containing 2% FBS). The detection method is detailed in Method 4. The specific coating solution settings are shown in Table 4. The bold italic numbers in the table represent values where the correction value exceeds 2 times the negative control value (positive result). The ELISA color development results are shown in the left figure, and the OD value measured by the microplate reader is shown in the right figure. The results show that the P antibody can effectively detect adenovirus particles by the ELISA method.
[0121] Table 4 P antibody ELISA detection of adenovirus
[0122]
[0123] Comparative Example 1
[0124] Comparison of the effectiveness of P antibody, 31penton antibody and Ad5 antibody in detecting polymorphic adenovirus (using Western-blot method, results are shown in Fig.10 ).
[0125] The Ad5 antibody (abcam, ab36851) compared with the detection effect of the P antibody, and the antibody obtained by immunizing rabbits with the penton protein of adenovirus type 31 (protein sequence number: OQ657093, the immunization method is consistent with the immunization method of the present invention) expressed in this laboratory (hereinafter referred to as 31P antibody), all three antibodies were diluted to a concentration of 1μg / mL with 1% skim milk, and the corresponding secondary antibodies (horseradish-labeled goat anti-rabbit and donkey anti-goat) were also diluted to 1μg / mL with 1% skim milk. The specific operation is shown in Method 2. When the specimen concentration and antibody concentration are consistent, the P antibody can detect all adenovirus strains with obvious bands, while the other two antibodies can only detect some adenovirus strains. The detection effect of the P antibody is better than the other two antibodies.
[0126] Note: Both P antibody and 31penton antibody detect adenovirus by measuring the penton protein of adenovirus.
[0127] The commercially available adenovirus antibodies are whole virus antibodies, so they can detect the three main capsid proteins of adenovirus, Hexon ( Fig.10 The top arrow points to the Penton ( Fig.10 The middle arrow points to) and Fiber ( Fig.10 The bottom arrow points to the right.
[0128] Comparative Example 2
[0129] Comparison of the effectiveness of P antibody and Ad5 antibody in detecting polymorphic adenovirus (cellular immunoenzymatic method, see Fig.11 , observed under 20x objective lens).
[0130] When P antibody and Ad5 antibody detected polytypic adenovirus infected CaCO-2 cells (human rectal cancer cells), under the condition of consistent cell amount (96-well plate), virus amount, infection time (48 hours), and antibody concentration (primary and secondary antibodies were 1 μg / mL), P antibody detected cells infected with the representative strain of adenovirus group AF (dark brown staining), and the effect was much better than Ad5 antibody in terms of both quantity and color development.
[0131] Comparative Example 3
[0132] Comparison of the effectiveness of P antibody and Ad5 antibody in detecting polymorphic adenovirus (ELISA method, see Fig.12 )
[0133] P antibody and Ad5 antibody were used to detect seven adenoviruses, A31 (A group 31 adenovirus), B3 (B group 3 adenovirus), C2 (C group 2 adenovirus), D8 (D group 8 adenovirus), E4 (E group 4 adenovirus), F40 (F group 40 adenovirus), F41 (F group 41 adenovirus), using ELISA method. The negative control was 2% MEM (the culture medium used for virus isolation: MEM containing 2% FBS). The detection method is detailed in Method 4. The specific coating solution settings are shown in Table 5. The correction value in the table is twice the negative control value, which is positive. The ELISA color development results are shown in the left figure, and the OD value measured by the microplate reader is shown in the right figure. The results show that both P antibody and Ad5 antibody can effectively detect adenoviruses by ELISA method. P antibody is inferior to Ad5 antibody in detection of C2, but better than Ad5 antibody in detection of the other six adenovirus types.
[0134] Table 5 Detection of adenovirus by ELISA with P antibody and Ad5 antibody
[0135]
[0136] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creative work, and these embodiments all fall within the scope of protection of the present invention.
Claims
1. A polypeptide composition for preparing a universal detection antibody for polymorphic adenovirus, characterized in that: The polypeptide composition is P1-A, P1-C and P2, the amino acid sequence of P1-A is shown as SEQ ID NO.1, the amino acid sequence of P1-C is shown as SEQ ID NO.2, and the amino acid sequence of P2 is shown as SEQ ID NO.
3.
2. An artificial antigen composition, characterized in that: The polypeptide composition according to claim 1 is coupled with a carrier protein.
3. The artificial antigen composition according to claim 2, characterized in that: The carrier protein is keyhole limpet hemocyanin.
4. Use of the polypeptide composition according to claim 1 or the artificial antigen composition according to claim 2 or 3 in the preparation of a reagent for detecting adenovirus penton protein.
5. Use of the polypeptide composition according to claim 1 or the artificial antigen composition according to claim 2 or 3 in the preparation of a reagent for detecting polymorphic adenovirus.
6. The use according to claim 5, characterized in that: The polytypic adenovirus is one or more of type A adenovirus, type B adenovirus, type C adenovirus, type D adenovirus, type E adenovirus and type F adenovirus.
7. Use of the polypeptide composition according to claim 1 or the artificial antigen composition according to claim 2 or 3 in preparing a diagnostic kit for adenovirus-induced diseases.
